» Articles » PMID: 26874686

Deep Characterization of Blood Cell MiRNomes by NGS

Abstract

A systematic understanding of different factors influencing cell type specific microRNA profiles is essential for state-of-the art biomarker research. We carried out a comprehensive analysis of the biological variability and changes in cell type pattern over time for different cell types and different isolation approaches in technical replicates. All combinations of the parameters mentioned above have been measured, resulting in 108 miRNA profiles that were evaluated by next-generation-sequencing. The largest miRNA variability was due to inter-individual differences (34 %), followed by the cell types (23.4 %) and the isolation technique (17.2 %). The change over time in cell miRNA composition was moderate (<3 %) being close to the technical variations (<1 %). Largest variability (including technical and biological variance) was observed for CD8 cells while CD3 and CD4 cells showed significantly lower variations. ANOVA highlighted that 51.5 % of all miRNAs were significantly influenced by the purification technique. While CD4 cells were least affected, especially miRNA profiles of CD8 cells were fluctuating depending on the cell purification approach. To provide researchers access to the profiles and to allow further analyses of the tested conditions we implemented a dynamic web resource.

Citing Articles

Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.

Li C, Wu A, Song K, Gao J, Huang E, Bai Y Cells. 2021; 10(12).

PMID: 34944012 PMC: 8700362. DOI: 10.3390/cells10123504.


MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients.

Heinicke F, Zhong X, Flam S, Breidenbach J, Leithaug M, Maehlen M Front Immunol. 2021; 12:663736.

PMID: 33897713 PMC: 8062711. DOI: 10.3389/fimmu.2021.663736.


MicroRNAs as Candidate Biomarkers for Alzheimer's Disease.

Kanach C, Blusztajn J, Fischer A, Delalle I Noncoding RNA. 2021; 7(1).

PMID: 33535543 PMC: 7930943. DOI: 10.3390/ncrna7010008.


Common diseases alter the physiological age-related blood microRNA profile.

Fehlmann T, Lehallier B, Schaum N, Hahn O, Kahraman M, Li Y Nat Commun. 2020; 11(1):5958.

PMID: 33235214 PMC: 7686493. DOI: 10.1038/s41467-020-19665-1.


HumiR: Web Services, Tools and Databases for Exploring Human microRNA Data.

Solomon J, Kern F, Fehlmann T, Meese E, Keller A Biomolecules. 2020; 10(11).

PMID: 33233537 PMC: 7699549. DOI: 10.3390/biom10111576.


References
1.
Yu I, Espinoza D, McAlexander M, Witwer K . OpenArray profiling reveals no differential modulation of miRNA by positive and negative CD4+ T cell immunoselection. Exp Hematol. 2013; 42(1):11-3. PMC: 4136421. DOI: 10.1016/j.exphem.2013.09.011. View

2.
Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller S, Frese K . A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013; 14(7):R78. PMC: 4053778. DOI: 10.1186/gb-2013-14-7-r78. View

3.
Kummerow C, Schwarz E, Bufe B, Zufall F, Hoth M, Qu B . A simple, economic, time-resolved killing assay. Eur J Immunol. 2014; 44(6):1870-2. DOI: 10.1002/eji.201444518. View

4.
Friedlander M, Mackowiak S, Li N, Chen W, Rajewsky N . miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2011; 40(1):37-52. PMC: 3245920. DOI: 10.1093/nar/gkr688. View

5.
Roth P, Keller A, Hoheisel J, Codo P, Bauer A, Backes C . Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients. Eur J Cancer. 2014; 51(3):382-90. DOI: 10.1016/j.ejca.2014.10.028. View